[Form 4] MARIMED INC. Insider Trading Activity

Rhea-AI Filing Summary

Mario Pinho, Chief Financial Officer of MARIMED INC. (MRMD), reported transactions dated 09/30/2025 related to restricted stock units (RSUs) granted earlier in 2025. On that date 53,572 RSUs were reported as acquired (Code M) and converted one-for-one into common stock, resulting in 53,571 shares beneficially owned from those RSUs. The issuer withheld 15,347 shares to satisfy tax withholding, recorded as a disposition at a price of $0.1635 per share, leaving the reporting person with 195,611 shares beneficially owned after the transactions. The RSUs were originally granted on February 17, 2025 and the remaining RSUs will vest on December 31, 2025 per the award agreement.

Insights

Financial Analyst

TL;DR: CFO received vested RSUs converted to shares; tax withholding reduced net shares; transactions are routine compensation-related events.

The filing shows a standard equity compensation vesting event for an executive rather than an open-market purchase or sale. Conversion of 53,572 RSUs into common stock increases the CFO's direct holdings while the issuer withheld 15,347 shares to satisfy taxes, recorded as a disposition at $0.1635 per share. These are non-cash compensation mechanics that modestly increase outstanding shares and reflect planned vesting under the award agreement dated February 17, 2025. For investors, this is a disclosure of insider compensation and ownership change but does not, by itself, indicate a change in company fundamentals.

Corporate Governance Expert

TL;DR: The report documents compliance with Section 16 disclosure for an executive equity award vesting and related tax withholding.

The Form 4 is consistent with timely reporting of beneficial ownership changes by an officer. It discloses vesting schedule details: grant date February 17, 2025 and remaining vesting on December 31, 2025. Reporting demonstrates transparency on insider compensation and tax withholding practices. There are no indications of opportunistic sales or unusual transfers; the transactions appear to follow standard award terms and withholding procedures required by the issuer.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Pinho Mario

(Last) (First) (Middle)

C/O MARIMED INC.

10 OCEANA WAY

(Street)

NORWOOD MA 02062

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MARIMED INC. [ MRMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	09/30/2025		M		53,572	A	$0(1)	210,958	D
Common stock	09/30/2025		F		15,347(2)	D	$0.1635	195,611	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units (RSU)	(1)	09/30/2025		M			53,572	(3)	(3)	Common Stock, par value $.001 per share	53,572	$0	53,571	D

Explanation of Responses:

1. RSUs convert to shares of common stock on a one-for-one basis.

2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.

3. The RSUs were granted on February 17, 2025; the remaining RSUs will vest on December 31, 2025 in accordance with the terms of an award agreement between the Issuer and the Reporting Person.

Remarks:

	/s/ Mario Pinho	09/30/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.